Wellth Daily Member Relationship Platform
Daily member engagement platform that drives care plan adherence through behavioral economics and personalized rewards
Platform · Cloud SaaSCompany source
Company profile
About Wellth
Wellth is a digital health company that transforms healthcare outcomes by building daily relationships between health plans and their members. The platform uses behavioral economics principles and structured rewards to drive medication adherence, care plan compliance, and quality metric improvements across diverse populations. Members receive personalized daily reminders for essential health tasks like taking medications or checking blood glucose, then verify compliance through simple photo uploads in the Wellth app. Consistent engagement unlocks meaningful financial incentives that address social determinants of health. The company serves Medicare Advantage and D-SNP plans, Medicaid programs, healthcare providers, employers, and ACA Marketplace plans. Wellth's approach has been validated through randomized controlled trials and delivers proven outcomes including 90% average care plan adherence, 2-4x ROI on cost of care reduction, and 43% average reduction in high-cost utilization. The platform integrates seamlessly within existing workflows, requires no additional devices, and can be implemented in 30 days. Founded by CEO Matthew Loper after witnessing the profound impact of care plan adherence on family members with type 2 diabetes, Wellth is committed to empowering individuals with the motivation and support needed to follow their care plans and build lasting healthy habits.
Company description Wellth official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Wellth?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Chronic diseases
- Complex chronic conditions
- High-risk acute coronary syndrome (ACS)
- Type 2 diabetes
Who it serves
- ACA Marketplace plans
- D-SNP plans
- Employers
- Healthcare providers
- Medicaid programs
- Medicare Advantage plans
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Over 70 million daily check-ins completed. Platform serving complex chronic, rising risk, and healthy populations simultaneously across multiple lines of business.
Partnerships
Recorded partners
- AdventHealth
- Penn Medicine
- Tokio Marine
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
The effects of an anti-inflammatory diet alone or in combination with acupuncture on mental health, anthropometric indices, and metabolic status in diabetic patients with depression: a randomized, controlled clinical trial.Nutrition & diabetes · May 2, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
90% average care plan adherence
Across member populations
2-4x ROI on cost of care reduction
For health plan partners
43% average reduction in high-cost utilization
Across chronic care populations
4+ Star Ratings
Across Part C & D measures
16% increased PDC medication adherence
Proportion of Days Covered improvement
51% lower inpatient admissions
Compared to baseline
45% reduction in hospital readmissions
Post-ACS patients in RCT
86% of members improved PDC
Penn Medicine case study
1,000+ touch points per member per year
Daily engagement model
AdventHealth
Reducing hospital readmissions post-acute coronary syndrome (ACS)
45% reduction in hospital readmissions post-ACS (RCT)
Medicare Plan (unnamed)
Reducing hospitalizations and improving quality performance for Medicare members
Fewer hospitalizations and improved quality performance
Penn Medicine
Improving medication adherence measured by Proportion of Days Covered (PDC)
86% of members improved PDC
Tokio Marine
Reducing hospital readmissions for high-risk patients
Driving down readmissions for high-risk patients
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Matt Loper
Co-Founder & Chief Executive Officer
Alec Zopf
Co-Founder & Advisor
John Snyder
Chief Operating Officer
Russ Gagnon
Chief Product Officer
Autri Chattopadhyay
Chief Strategy Officer
Karen Moran
Chief Financial Officer
David Nackoul
SVP of Engineering
Samantha Cordero
SVP, Program Operations
06 · Company updates
Updates from Wellth
Recent articles published on Wellth's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.